J. Hutchinson, A. Fogarty, R. Hubbard, and T. Mckeever, Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review, Eur Respir J. sept, vol.46, issue.3, pp.795-806, 2015.

G. Raghu, H. R. Collard, J. J. Egan, F. J. Martinez, J. Behr et al., An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management, Am J Respir Crit Care Med. 15 mars, vol.183, issue.6, pp.788-824, 2011.

G. Raghu, M. Remy-jardin, J. L. Myers, L. Richeldi, C. J. Ryerson et al., Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline, Am J Respir Crit Care Med. 1 sept, vol.198, issue.5, pp.44-68, 2018.

G. Raghu, S. Chen, W. Yeh, B. Maroni, Q. Li et al., Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, Lancet Respir Med. juill, vol.2, issue.7, pp.566-72, 2014.

N. P. Barlo, Predicting prognosis in idiopathic pulmonary fibrosis, p.11

M. Selman, G. Carrillo, A. Estrada, M. Mejia, C. Becerril et al., Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PloS One. 30 mai, vol.2, p.482, 2007.

A. C. Best, J. Meng, A. M. Lynch, C. M. Bozic, D. Miller et al., Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality, Radiology. mars, vol.246, issue.3, pp.935-975, 2008.

D. A. Lynch, J. D. Godwin, S. Safrin, K. M. Starko, P. Hormel et al., High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis: Diagnosis and Prognosis, Am J Respir Crit Care Med. 15 août, vol.172, issue.4, pp.488-93, 2005.

T. Watadani, F. Sakai, T. Johkoh, S. Noma, M. Akira et al., Interobserver Variability in the CT Assessment of Honeycombing in the Lungs, Radiology. mars, vol.266, issue.3, pp.936-980, 2013.

J. Jacob, B. J. Bartholmai, S. Rajagopalan, M. Kokosi, A. Nair et al., Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function, J Thorac Imaging. sept, vol.31, issue.5, pp.304-315, 2016.

J. Jacob, B. J. Bartholmai, S. Rajagopalan, M. Kokosi, A. Nair et al., Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures, Eur Respir J. janv, vol.49, issue.1, p.1601011, 2017.

J. Jacob, B. J. Bartholmai, S. Rajagopalan, R. Egashira, A. L. Brun et al., Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices, Respir Med. sept, vol.130, pp.43-51, 2017.

J. Jacob, B. J. Bartholmai, R. Egashira, A. L. Brun, S. Rajagopalan et al., Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis, BMC Pulm Med, vol.17, issue.2, 2017.

D. Sur,

M. Colombat, H. Mal, O. Groussard, F. Capron, G. Thabut et al., Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics, Hum Pathol. janv, vol.38, issue.1, pp.60-65, 2007.

S. Shin, C. S. King, N. Puri, O. A. Shlobin, A. W. Brown et al., Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis, Eur Respir J. mai, vol.47, issue.5, pp.1445-51, 2016.

H. R. Collard, K. T. Bartelson, B. B. Vourlekis, J. S. Schwarz, M. I. Brown et al., Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.168, pp.538-542, 2003.

R. M. Bois, D. Weycker, C. Albera, W. Z. Bradford, U. Costabel et al., Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference, Am J Respir Crit Care Med. 15 déc, vol.184, issue.12, pp.1382-1391, 2011.

K. R. Flaherty, J. A. Mumford, S. Murray, E. A. Kazerooni, B. H. Gross et al., Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia, Am J Respir Crit Care Med. sept, vol.168, issue.5, pp.543-551, 2003.

A. U. Wells, S. R. Desai, R. M. Goh, N. S. Cramer, D. Nicholson et al., Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography, American Journal of Respiratory and Critical Care Medicine, vol.167, pp.962-969, 2003.

E. A. Renzoni, D. A. Walsh, M. Salmon, A. U. Wells, P. Sestini et al., Interstitial vascularity in fibrosing alveolitis, Am J Respir Crit Care Med. 1 févr, vol.167, issue.3, pp.438-481, 2003.

M. Ebina, M. Shimizukawa, N. Shibata, Y. Kimura, T. Suzuki et al., Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis, Am J Respir Crit Care Med. 1 juin, vol.169, issue.11, pp.1203-1211, 2004.

G. P. Cosgrove, K. K. Brown, W. P. Schiemann, A. E. Serls, J. E. Parr et al., Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis, Am J Respir Crit Care Med. 1 août, vol.170, issue.3, pp.242-51, 2004.

F. Coste, G. Dournes, C. Dromer, E. Blanchard, V. Freund-michel et al., CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension, Thorax, vol.71, pp.830-837, 2016.

S. Matsuoka, G. R. Washko, M. T. Dransfield, T. Yamashiro, S. Estepar et al., Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD, Academic Radiology, vol.17, pp.93-99, 2010.

L. Wémeau-stervinou, T. Perez, C. Murphy, A. Polge, and B. Wallaert, Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia, Respir Med. avr, vol.106, issue.4, pp.564-70, 2012.

D. Visca, L. Mori, V. Tsipouri, S. Fleming, A. Firouzi et al., Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial, Lancet Respir Med. 28 août, 2018.

O. Nishiyama, H. Taniguchi, Y. Kondoh, T. Kimura, T. Ogawa et al., Healthrelated quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor, Respir Med. avr, vol.99, issue.4, pp.408-422, 2005.

K. R. Flaherty, A. Andrei, S. Murray, C. Fraley, T. V. Colby et al., Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test, Am J Respir Crit Care Med, vol.174, issue.7, pp.803-812, 2006.

V. N. Lama, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis et al., Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia, Am J Respir Crit Care Med, vol.168, issue.9, pp.1084-90, 2003.

T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes et al., The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis, Eur Respir J. janv, vol.25, issue.1, pp.96-103, 2005.